Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FBXW7 |
Variant | T165fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | FBXW7 T165fs results in a change in the amino acid sequence of the Fbxw7 protein beginning at aa 165 of 707, likely resulting in premature truncation of the functional protein (UniProt.org). T165fs has not been characterized however, due to the effects of other truncation mutations downstream of T165 (PMID: 30510140, PMID: 24838835), is predicted to lead to a loss of Fbxw7 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
FBXW7 mutant FBXW7 inact mut FBXW7 T165fs |
Transcript | NM_033632.3 |
gDNA | chr4:g.(152411311_152411312) |
cDNA | c.(493_492) |
Protein | p.T165fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_033632.3 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_024454123.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_033632 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_047415900.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_024454123.2 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532085.3 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532083 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532084.2 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_047415897.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_024454122.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_024454121.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_024454124.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_001257069.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_017008362 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_047415898.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532084 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532084.3 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_001257069 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532085.2 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_001257069.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_011532085 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_001349798.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_047415899.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
XM_047415901.1 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
NM_001349798.2 | chr4:g.(152411311_152411312) | c.(493_492) | p.T165fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|